Soleno Therapeutics, Inc. (NASDAQ:SLNO) ranks among the most oversold biotech stocks to invest in. Soleno Therapeutics, Inc. (NASDAQ:SLNO) reported third-quarter adjusted earnings of $0.47 per share ...
SOLENO THERAPEUTICS ($SLNO) posted quarterly earnings results on Wednesday, May 7th. The company reported earnings of -$0.95 per share, missing estimates of -$0.95 by ...
US Bancorp DE purchased a new position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) during the 4th quarter, Holdings Channel reports. The institutional investor purchased 748 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback